Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 27.54 | 16.34 |
| PEG Ratio (TTM) | -1.15 | 2.08 |
| P/S Ratio (TTM) | 2.42 | 1.48 |
| P/B Ratio (TTM) | 2.14 | 2.42 |
| P/FCF Ratio (TTM) | -15.30 | 13.10 |
| Price to 5YR AVG Earnings Ratio | N/A | 0.56 |
| Price to 5YR AVG FCF Ratio | N/A | 37.62 |
Profitability (15%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.12% | 8.40% |
| ROE (TTM) | 8.04% | 19.35% |
| Net Profit Margin (TTM) | 8.78% | 10.98% |
| ROIC 5YR AVG | N/A | 6.59% |
Growth (50%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -31.55% | 1,691.85% | N/A |
| Revenue | 20.29% | 87.14% | N/A |
| Net Income | -30.47% | 1,685.79% | N/A |
| Cash Flow | 23.08% | 326.95% | N/A |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.23 | 1.88 |
| Quick Ratio (TTM) | 1.00 | 1.34 |
| D/E Ratio (TTM) | 0.45 | 0.71 |
| Interest Coverage (TTM) | 20.63 | 14.26 |
| Piotroski F-Score | 6 | 7 |
| Altman Z-Score | 2.14 | 2.97 |
| LTL to 5YR AVG FCF | N/A | 8.20 |
| Shares Outstanding Growth 5YR AVG | N/A | 8.28% |